gao_reports: GAO-26-107877

Government Accountability Office reports (1994–2008) with abstracts, legal references, and subject classifications.

This data as json

package_id	title	date_issued	report_number	document_type	doc_class	abstract	subjects	public_laws	usc_references	statute_references	citation	pdf_url	html_url	detail_url	sudocs
GAO-26-107877	FDA Advisory Committees: More Transparency Needed on Policies for Making Conflict of Interest Determinations	2026-03-24	GAO-26-107877			The Food and Drug Administration relies on advisory committees for independent advice on developing and evaluating drugs and other products. If committee members have conflicts of interest—e.g., financial investments in what's being evaluated—they generally can't participate in meetings. We reviewed FDA's conflict of interest review process, and found that it hasn't finalized guidance on how to determine if a financial conflict exists. FDA also doesn't...								https://www.gao.gov/products/gao-26-107877